The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review

Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment

(2015) Maria Raffaella Petrara et al.   CANCER LETTERS

Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation

(2013) U. D. Allen et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effect of Cytomegalovirus Immunoglobulin on the Incidence of Lymphoproliferative Disease After Lung Transplantation

(2013) Peter Jaksch et al.   TRANSPLANTATION

Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection

(2013) Maria R. Petrara et al.   Frontiers in Microbiology

Epidemiology and Morbidity of Epstein-Barr Virus Infection in Pediatric Renal Transplant Recipients: A Multicenter, Prospective Study

(2012) Britta Höcker et al.   CLINICAL INFECTIOUS DISEASES

Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients

(2010) Cedric Manlhiot et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Risk Factors for Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients With Cytomegalovirus Antigenemia

(2010) J.M. Kim et al.   TRANSPLANTATION PROCEEDINGS

Multiple Clinical Presentations of Lymphoproliferative Disorders in Pediatric Liver Transplant Recipients: A Single-Center Experience

(2010) M.L. Pinho-Apezzato et al.   TRANSPLANTATION PROCEEDINGS

Gene expression using microarrays in transplant recipients at risk of EBV lymphoproliferation after organ transplantation: Preliminary proof-of-concept

(2009) Upton Allen et al.   PEDIATRIC TRANSPLANTATION

Epidemiology of Pretransplant EBV and CMV Serostatus in Relation to Posttransplant Non-Hodgkin Lymphoma

(2009) Gerhard Opelz et al.   TRANSPLANTATION

Timing of Epstein-Barr Virus Acquisition and the Course of Posttransplantation Lymphoproliferative Disorder in Children

(2009) Jia-Feng Wu et al.   TRANSPLANTATION

Impact of Valganciclovir on Epstein-Barr Virus Polymerase Chain Reaction in Pediatric Liver Transplantation: Preliminary Report

(2009) C. Venturi et al.   TRANSPLANTATION PROCEEDINGS

The Role of Valacyclovir on Epstein–Barr Virus Viral Loads in Pediatric Liver Transplantation Patients

(2009) F. Özçay et al.   TRANSPLANTATION PROCEEDINGS

Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients

(2009) S. Sevmis et al.   TRANSPLANTATION PROCEEDINGS

Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplantation

(2009) M. Uribe et al.   TRANSPLANTATION PROCEEDINGS

De Novo Malignancy After Solid Organ Transplantation in Children

(2009) D. Debray et al.   TRANSPLANTATION PROCEEDINGS

Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids

(2008) R. A. McDonald et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Relationship of Immunosuppression to Epstein–Barr Viral Load and Lymphoproliferative Disease in Pediatric Heart Transplant Patients

(2008) Stephan Schubert et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus

(2008) Loreto Hierro et al.   LIVER TRANSPLANTATION

Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients

(2008) S. Schubert et al.   PEDIATRIC TRANSPLANTATION

Post-transplant lymphoproliferative disorder after pediatric liver transplantation: Characteristics and outcome

(2008) María C. Fernández et al.   PEDIATRIC TRANSPLANTATION